invasive · VNS · shipping
LivaNova SenTiva
By LivaNova
Identity
- Manufacturer
- LivaNova
- Model number
- Model 1000verifiedSource
- FDA recall record — VNS Therapy SenTiva Generator Model 1000https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637
- Codename
- —unknownUpdated: 2026-05-04
- Aliases
- SenTiva, Cyberonics SenTiva, VNS Therapy SenTivaverifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
- Generation
- —unknownUpdated: 2026-05-04
- Country of origin
- USverifiedSource
- FDA recall record — VNS Therapy SenTiva Generator Model 1000https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637
- Released
- verifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Announced
- —unknownUpdated: 2026-05-04
- Discontinued
- —unknownUpdated: 2026-05-04
- Status
- shippingverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
Classification
- Invasiveness
- invasiveverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Modalities
- VNSverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Primary modality
- VNSverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Direction
- read-writeverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Categories
- medical-implant, stimulation, therapeuticverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Form factor
- implantverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Use cases
- adjunctive therapy for drug-resistant partial-onset seizures (age 4+), AutoStim closed-loop stimulation triggered by rapid heart-rate increaseverifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- FDA recall record — VNS Therapy SenTiva Generator Model 1000https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637
- Target users
- neurosurgeon, neurologist, patient-epilepsyverifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- FDA recall record — VNS Therapy SenTiva Generator Model 1000https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637
Electrodes
- Total channels
- 1verifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Recording channels
- 0verifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Reference channels
- —unknownUpdated: 2026-05-04
- Electrode type
- cuffverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Material
- platinum-iridiumverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- 10-20 positions
- —unknownUpdated: 2026-05-04
- Requires gel
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Requires saline
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Prep time
- —unknownUpdated: 2026-05-04
- Reusable
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Disposable
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
Auxiliary sensors
- IMU
- —unknownUpdated: 2026-05-04
- IMU axes
- —unknownUpdated: 2026-05-04
- Accelerometer
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Gyroscope
- —unknownUpdated: 2026-05-04
- Magnetometer
- —unknownUpdated: 2026-05-04
- PPG (heart rate)
- —unknownUpdated: 2026-05-04
- ECG
- YesverifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
- EMG
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- EOG
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- EDA / GSR
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Temperature
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Respiration
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Microphone
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Eye tracking
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
Stimulation
- Capable
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
Connectivity
- Protocols
- proprietary-rfverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Bluetooth
- —unknownUpdated: 2026-05-04
- Bluetooth profiles
- —unknownUpdated: 2026-05-04
- Concurrent mode
- single-onlyverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Encryption (transit)
- —unknownUpdated: 2026-05-04
- Pairing methods
- —unknownUpdated: 2026-05-04
- Cloud sync
- —unknownUpdated: 2026-05-04
- Offline recording
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
Power
- Sources
- non-rechargeableverifiedSource
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
- Battery life (active)
- —unknownSource
- Implant lifetime ~5–10 years per published reviews
- Charging port
- —unknownUpdated: 2026-05-04
- Charging time
- —unknownUpdated: 2026-05-04
- Battery replaceable
- NoverifiedSource
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
- Notes
- Primary lithium cell; generator replacement surgery at end-of-life.verifiedSource
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
Physical
- Weight
- —unknownSource
- v0 said 16.6 g; not pinned in primary sources
- Dimensions
- —unknownSource
- v0 listed 45 × 32 × 6.9 mm; not pinned in primary sources
- Materials
- titaniumverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Sizes
- —unknownUpdated: 2026-05-04
- Head circumference
- —unknownUpdated: 2026-05-04
- Operating temp
- —unknownUpdated: 2026-05-04
Compute
- Has onboard computer
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Operating systems
- custom-firmwareverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Primary OS
- custom-firmwareverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Edge ML accelerator
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Root access
- noneverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- App sandbox
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- 3rd-party apps allowed
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Notes
- Onboard heart-rate detection algorithm gates AutoStim therapy.verifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
Software & data
- Mobile app
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Cloud platform
- —unknownUpdated: 2026-05-04
- Offline mode
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Subscription required
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Raw data access
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Export formats
- —unknownUpdated: 2026-05-04
- LSL support
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Data ownership
- manufacturerverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Apps
- VNS Therapy Programming System (Model 3000)verifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
SDK & developer access
- Has SDK
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Open source
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Languages
- —unknownUpdated: 2026-05-04
- Web Bluetooth
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Raw sample access
- NoverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- BCI paradigms
- —unknownUpdated: 2026-05-04
- 3rd-party integrations
- —unknownUpdated: 2026-05-04
- Docs
- —unknownUpdated: 2026-05-04
Capabilities
- Attention / focus
- —unknownUpdated: 2026-05-04
- Meditation / calm
- —unknownUpdated: 2026-05-04
- Neurofeedback
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Meditation coaching
- —unknownUpdated: 2026-05-04
- Sleep tracking
- —unknownUpdated: 2026-05-04
Regulatory & clinical
- FDA status
- pmaverifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- FDA recall record — VNS Therapy SenTiva Generator Model 1000https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637
- CE mark
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Certifications
- —unknownSource
- v0 listed IEC-60601-1 / ISO-13485; not pinned in primary sources
- Prescription required
- YesverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Pediatric approved
- YesverifiedSources (2)
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- PMC — Evolution of the VNS Therapy System reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/
Pricing & availability
- MSRP
- —unknownSource
- v0 said ~$30k hardware-only; implant pricing is hospital-negotiated, not publicly listed
- Current price
- —unknownUpdated: 2026-05-04
- Subscription
- —unknownUpdated: 2026-05-04
- Warranty
- —unknownUpdated: 2026-05-04
- Return policy (days)
- —unknownUpdated: 2026-05-04
- Where to buy
- Buy at livanova.comverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
Media & links
- Official site
- livanova.comverifiedSource
- BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy2017-10-09
- Product page
- —unknownUpdated: 2026-05-04
Editor’s take
In favor
- Smallest, lightest VNS generator on the market
- Closed-loop AutoStim seizure response
- Multi-decade clinical track record (Cyberonics → LivaNova)
Against
- Generator replacement surgery every ~8 years
- Voice alteration is a common side effect
- Closed manufacturer ecosystem
Sources & provenance
- BusinessWire — LivaNova SenTiva FDA approval (2017-10-09)
- FDA recall record — SenTiva Generator Model 1000
- PMC — Evolution of the VNS Therapy System review
- Medical Device Network — LivaNova launches SenTiva DUO
Last reviewed